Pyrrolidine derivatives having phospholipase A.sub.2 inhibitory activity
US6147100A · kind A · utility
13Cited by
2References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 1999 |
| Grant date | Nov 14, 2000 |
| Priority date | — |
| Expiry date | Jul 22, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound represented by the formula (I): ##STR1## wherein, for example, R.sup.1 is optionally substituted aralkyl, Z is nitrogen atom which optionally substituted with alkyl, X.sup.1 is --CH.sub.2 NHCO--, X.sup.2 is phenylene, X.sup.3 is a bond, Y.sup.2 is optionally substituted aryl, B is oxygen atom, its pharmaceutically acceptable salt, or hydrate thereof and a pharmaceutical composition which contains them as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.